Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hani Abdeltawab
Observed name:
Abdeltawab, Hani Ibrahim Abdelaziz
Institution:
University of Auckland
Observed institution:
University of Auckland
ORCID:
0000-0002-3130-6761
Observed ORCID:
0000-0002-3130-6761
OpenAlex ID:
A5033775914
Formulation strategies to modulate drug release from poloxamer based in situ gelling systems
2020
·
Hani Abdeltawab
, Darren Svirskis
, et al.
·
Expert Opinion on Drug Delivery
·
165
Injectable thermoresponsive gels offer sustained dual release of bupivacaine hydrochloride and ketorolac tromethamine for up to two weeks
2021
·
Hani Abdeltawab
, Darren Svirskis
, et al.
·
International Journal of Pharmaceutics
·
32
PDF
Increasing the Hydrophobic Component of Poloxamers and the Inclusion of Salt Extend the Release of Bupivacaine from Injectable In Situ Gels, While Common Polymer Additives Have Little Effect
2022
·
Hani Abdeltawab
, Darren Svirskis
, et al.
·
Gels
·
24
PDF
Sustained Delivery of Lactoferrin Using Poloxamer Gels for Local Bone Regeneration in a Rat Calvarial Defect Model
2021
·
Young Eun Park
, Kaushik Chandramouli
, et al.
·
Materials
·
11
PDF
In situ gelling system for sustained intraarticular delivery of bupivacaine and ketorolac in sheep
2022
·
Hani Abdeltawab
, Scott M. Bolam
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
6
Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking Cessation
2022
·
Eileen Hulambukie
, Hani Abdeltawab
, et al.
·
Gels
·
3
PDF
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use
2021
·
Hani Abdeltawab
, Jagdish Kumar Jaiswal
, et al.
·
European Journal of Hospital Pharmacy
·
3
PDF
Show more works
View as search
Works count:
8
Citation count:
244
H-index:
5
I10-index:
4
Year
Topic
Type